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Abstract  
AIM: To determine the effects of polyphenol-rich extract of the leaves of Vernonia amygdalina 
(PEVA) in rats with Cd-induced nephropathy.  
MATERIALS AND METHODS: Sixty five male Wistar rats were divided into five groups as follows; 
Group 1 received distilled water throughout the period of study. Group 2 received 5 mg/kg body 
weight of cadmium (Cd), in the form of CdSO4, for five consecutive days via intraperitoneal route. 
Groups 3, 4 and 5 were pretreated with Cd as group 2 and thereafter received oral treatment of 
PEVA for 4 weeks at 100 mg/kg, 200 mg/kg and 400 mg/kg body weight, respectively.  
RESULTS: Exposure to Cd toxicity significantly induced deleterious alterations in plasma and urine 
levels of creatinine, urea and glucose as well as creatinine and urea clearance (p < 0.05) in the rat 
model. There was a significant disturbance in the antioxidant system as revealed by the levels of 
thiobarbituric acid reactive substance (TBARS) and reduced glutathione (GSH) (p < 0.05) in the 
kidney tissue of the rats. With marked improvements in renal histoarchitecture, PEVA treatment 
showed a duration and non dose-dependent ameliorative potential.  
CONCLUSION: PEVA treatment reversed the compromise of renal function that was induced by 
Cd toxicity in rat model. 
 
 
 
 
 
 
 
Introduction 
 
Cadmium is a ubiquitous non-essential heavy 
metal of importance in several industrial processes 
[1]. Its inability to undergo metabolic degradation to 
less toxic metabolites makes its exposure a serious 
health concern [2]. There is increasing concern about 
its contamination of soil and water as it bioaccumulate 
in the food chain, particularly in regions of inadequate 
exposure-control. Hence, consumption of 
contaminated food is a greater part of its intake in 
humans [3, 4]. A further contribution to human 
exposure is the considerable portion it occupies in 
tobacco/cigarette [1, 4], thus exerting its toxic effects 
in both active and passive smokers. Unlike most 
heavy metals, exposures to cadmium can induce 
disruptions in a number of biological activities and 
systems at relatively lower doses [5-7]. Its toxicity, 
basically, affects the vital organs of the body. 
However, its main repository organ is the kidney [4, 8, 
9]. 
According to the National Association of 
Nephrology (NAN, Nigeria), about 30 million Nigerians 
have chronic kidney disease [10]. This staggering 
figure was corroborated by the National Kidney 
Foundation (NFK, USA) that about 27 million 
Nigerians have chronic kidney disease. This precursor 
to kidney failure is with an incidence of 100 per million 
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populations (about 15,000 new cases every year) and 
prevalence of 300 to 400 million (about 45,000 living 
with kidney failure annually) [10]. The incidence of 
kidney disease is on the increase (worldwide) with 
high cost of management or treatment. Cadmium is 
reputed for its nephrotoxic effect. The use of 
established antagonists and various chelating agents 
to reduce its toxicity is usually associated with 
undesirable side effects [11]; hence current scientific 
research is geared towards exploiting the health 
benefits of natural products of plant origin. These 
plants are usually common and relatively cheaper, yet 
with promising health-boosting potentials. 
Various vegetables, fruits and whole grains 
are examples of abundant sources of polyphenols 
[12]. Polyphenols are strong antioxidants which act as 
a defense against reactive oxygen species (ROS)-
induced oxidative stress [13]. They are reputed for 
complementing and adding to the functions of 
antioxidant enzymes and vitamins [13]. The study of 
the biological effects of polyphenols has become an 
area of interest in the light of recent advances in the 
field of nutrition and medical sciences [14].  
Vernonia amygdalina leaf (commonly called 
bitter leaf) is reputed for its many medicinal benefits 
which range from anti-inflammatory, antidiabetic [10], 
bad and total cholesterol-reducing [15], cardiovascular 
disease-ameliorating [16], immune system-
strengthening, anti-microbial [10], anti-diarrhea, and 
anti-emetic [17] potentials, to mention a few. However, 
the health benefits of this apparently medicinal plant 
have been attributed, by most literature, to the 
presence of polyphenols in its extract [15-17]. The 
effects of this polyphenol-rich extract on cadmium-
induced kidney injury have not been reported, hence 
this study. 
 
 
Material and Methods 
 
Plant, Materials and Chemicals 
Fresh leaves of Vernonia amygdalina were 
obtained from a garden in Ife-Ibadan area of Ile-Ife, 
Osun State, Nigeria. This was certified by a 
Taxonomist (Mr. A. Gabriel) in the Department of 
Botany, Obafemi Awolowo University (OAU), Ile-Ife, 
Osun State, Nigeria. 
Ohaus R Model of metabolic cage (Ohaus, 
Pine Brook, New Jersey, USA) was used for this 
study. Standard Laboratory kits for assay of indices of 
renal function were purchased from Randox 
Laboratories Limited, United Kingdom. Acetone was 
purchased from Crescent Chemical Co., Inc, New 
York, United States while Cadmium sulphate was 
purchased from Guangzhou Fischer Chemical Co., 
Ltd, Guangdong, China. 
Extraction of Polyphenols 
Using standard procedure, polyphenol-rich 
extract of leaves of Vernonia amygdalina (PEVA) was 
obtained as follows; the leaves were air-dried and 
pulverized with an Electric Pulverizer (DIK-2910, Daiki 
Rika Kogyo Co. Ltd, Tokyo-Japan) and thereafter 
weighed. This was further crushed in 80% acetone 
(1:2 w/v) using a Waring blender (Waring Commercial, 
Torrington, CT). The sample was homogenized in a 
Polytron Homogenizer (Glen Mills Inc., Clifton, NJ) for 
3 minutes and the homogenates was filtered under 
vacuum using Buchner funnel and Whatman number 
2 Filter Paper (Whatman PLC, Middlesex, UK). The 
filtrate was concentrated under vacuum using a 
Rotary Evaporator (HahnShin Scientific, HS-2005-N) 
and freeze-dried in a Lyophilizer (Ilshin Lab. Co. Ltd, 
Seoul, Republic of Korea). The yield obtained (PEVA) 
was weighed and kept in a desiccator until when 
needed. The percentage (%) yield of PEVA was 
calculated as shown below; 
% yield of PEVA = yield of PEVA ÷ weight of pulverized leaves x 
100 % [18]. 
As reported in our earlier study, the total 
phenol content was determined to be 681 ± 47.36 mg 
of gallic acid equivalent per gramme of the extract 
while the total flavonoids content was 23.70 ± 1.78 mg 
of quercetin equivalent per gramme of the extract [19]. 
 
Solutions of PEVA Extract and Cadmium Salt 
Polyphenol-rich extract of leaves of Vernonia 
amygdalina (PEVA) was reconstituted with distilled 
water to prepare three stock solutions. One gramme 
(1 g) of PEVA was dissolved in 20 ml of distilled water 
to obtain a stock solution for 100 mg/kg of PEVA. 
Also, 2 g and 4 g of PEVA were each dissolved in 20 
ml of distilled water to obtain stock solutions for 200 
mg/kg and 400 mg/kg of PEVA, respectively. This 
implies that the rats received graded doses of PEVA 
at 100, 200 and 400 mg/kg body weight, respectively. 
The choice of therapeutic doses for this study was 
guided by the predetermined oral LD50 of PEVA (and 
taken to be ≤ 10% of oral LD50), as reported in our 
previous study [19]. Therefore, the extracts were 
administered at 0.2 ml per 100 g body weight of rats. 
Fresh samples were prepared every 48 hours and 
stored in a deep-freezer after use. 
Fifty milligram (50 mg) of cadmium sulphate 
salt was dissolved in 20 ml of distilled water and 
administered to rats at 0.2 ml/ 100 g bodyweight. This 
implies that 0.5 mg of cadmium solution was 
administered to 100 g rat. Renal injury was induced by 
the administration of solution of Cd at a dose of 5 
mg/kg/day for five consecutive days, via 
intraperitoneal route (i.p.). 
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Animal Management and Experimental 
Protocol 
The experimental protocols were in strict 
compliance with the guide for animal research, as 
detailed in the NIH Guidelines for the Care and Use of 
Laboratory Animals (National Academy of Sciences 
and National Institutes of Health Publications, 2011) 
[20] and approved by local Institutional Research 
Committee. Sixty five (65) male Wistar rats, weighing 
150-175 g, were used for this study. They were 
purchased from the Animal Holdings of the College of 
Health Sciences, OAU, Ile-Ife, Osun State, Nigeria; 
where the study was carried out. Each rat was housed 
in a separate metabolic cage under natural light/dark 
cycle and allowed to have access to standard 
laboratory rat chow (Caps Feed PLC Osogbo, Nigeria) 
and water ad libitum. The rats were allowed to 
acclimatize in the metabolic cage for 2 weeks before 
the commencement of this study, to allow for 
adaptation to life in metabolic cage.  
Table 1: Experimental Protocol and Dose Regimen 
 DAY 5 WEEK 2 WEEK 4 WEEK 6 
GROUP 1 DW DW DW DW* 
GROUP 2 Cd* RP * RP *  
GROUP 3 Cd P 100 mg/kg* 100 mg/kg* RP * 
GROUP 4 Cd P 200 mg/kg* 200 mg/kg* RP * 
GROUP 5 Cd P 400 mg/kg* 400 mg/kg* RP * 
DW= Distilled water; Cd= Cadmium (5 mg/kg bw via intraperitoneal route); P= Polyphenol-
rich extract of leaves of Vernonia amygdalina (PEVA); RP= Recovery period; Group 1= 
Control (5 rats); Group 2= Toxic Control (15 rats); Group 3= Cd + 100 mg/kg PEVA (15 
rats); Group 4= Cd + 200 mg/kg PEVA (15 rats); Group 5= Cd + 400 mg/kg PEVA (15 
rats); *= point that rats were euthanized. 
 
The rats were divided into five (5) groups as 
follows; Group 1 (control group) consisted of 5 rats 
that received distilled water at 0.2 ml/100 g body 
weight, throughout the study period (6 weeks) after 
which they were sacrificed. Group 2 (toxic group) 
consisted of 15 rats each of which received Cadmium 
(Cd) at 5 mg/kg in the form of CdSO4 via 
intraperitoneal route, once daily, for five consecutive 
days. Five of the rats were sacrificed 24 hours after 
Cd intoxication.  
From the remaining 10 rats, 5 each were 
sacrificed after a recovery period of 2 and 4 weeks. 
Groups 3, 4 and 5 consisted of 15 rats each, which 
were also intoxicated with Cd as stated above. 
Thereafter, they received 100, 200 and 400 mg/kg of 
PEVA respectively, via oral route of which 5 rats were 
sacrificed after 14 days. The remaining 10 rats in each 
group received the respective doses of PEVA for 28 
days of which 5 rats were sacrificed, twenty four 
hours, after the last dose of PEVA while the remaining 
5 rats were sacrificed after 2 weeks of recovery 
period.  
Blood samples were collected by cardiac 
puncture into separate EDTA bottles and centrifuged 
at 4000 rpm for 15 minutes with the aid of a cold 
centrifuge (Centurium Scientific, Model 8881) at -4ºC 
in order to obtain the plasma. Plasma obtained was 
collected into separate plain bottles for the 
assessment of the indices of renal function. 
Measurement of Body Weight and Food 
Consumption 
With the aid of a digital weighing balance 
(Hanson, China), weekly body weight and food 
consumption of the rats were measured. The food 
consumption was measured by subtracting the final 
amount from the initial amount that was measured a 
day before. The value obtained was taken to be the 
amount consumed by each rat. 
 
Collection and Measurement of Urine 
Samples 
With the aid of the metabolic cage, urine 
samples of rats were collected into separate plastic 
containers. Urine volumes were read off directly with 
the aid of a measuring cylinder and volumes that were 
less than 1ml were measured with the aid of an insulin 
syringe. 
 
Biochemical Assays 
Plasma and urine levels of creatinine, urea and 
glucose were estimated using standard laboratory 
protocols, as provided by Randox Laboratories. 
Creatinine and urea clearance were calculated using 
conventional formulae as follows; 
Clearance= UV/P (ml/min). 
Where U= concentration of substance in urine; 
V= urine flow rate = amount of urine/ time (secs); and 
P= concentration of substance in plasma. 
 
Homogenate Preparation 
The kidneys of the rats were carefully excised 
and weighed. One of the kidneys (left) was 
homogenized with 10ml of sucrose solution (0.25M) 
using Electric Homogenizer (SI601001). 10% 
homogenate in phosphate buffer (100 Mm) was 
prepared at pH of 7.4. The homogenate was 
centrifuged at 3000 rpm for 20 minutes and the 
supernatant was collected for the assessment of 
levels of lipid peroxidation and oxidative stress.  
 
Assay for Non-enzymatic Antioxidant Status 
Reduced glutathione (GSH) levels were 
measured by the method of Beutler and Kelly [21]. 1 
ml of the supernatant, obtained above, was added to 
0.5 ml of Ellman’s reagent (10 mM). 2 ml of phosphate 
buffer (0.2 M, pH 8.0) was, thereafter, added. The 
yellow colour developed was read at 412 nm against 
blank containing 3.5 ml of phosphate buffer. A series 
of standards were also treated similarly and the 
amount of GSH was expressed in mg/100 g tissue. 
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Assay for Lipid Peroxidation 
Levels of thiobarbituric acid reactive 
substance (TBARS) were determined by the method 
of Ohkawa et al [22]. To each 0.5 ml of the 
supernatant was added 0.5 ml of phosphate buffer 
(0.1 M, pH 8.0) and 0.5 ml of 24% TCA. The resulting 
mixture was incubated at room temperature for 10 
min, followed by centrifugation at 2000 rpm for 20 min. 
To 1 ml of the resulting supernatant was added 0.25 
ml of 0.33% TBA in 20% acetic acid and the resulting 
mixture was boiled at 95
o
C for 1 hr. The resulting pink 
colour product was cooled and absorbance was read 
at 532nm (Extinction coefficient of TBARS; ε532 = 
1.53 x 105 M
-1
 cm
-1
). 
 
Histopathological Studies 
The right kidneys of the rats were fixed in 
10% formal-saline solution. They were, thereafter, 
dehydrated in graded alcohol and embedded in 
paraffin wax. Sections taken (7-8 µm thick) were 
stained, using Hematoxylin and Eosin (H & E) 
technique, for photomicroscopic assessment with the 
aid of Leica DM 750 camera microscope at 
magnifications of x400. 
 
Statistical Analysis 
The results obtained were collated and 
expressed as Mean ± Standard Error of Mean (S.E.M) 
and subjected to one-way analysis of variance 
(ANOVA). The data were further subjected to a post 
hoc test using Student Neumann Keuls’ method, and 
differences with probability values of p < 0.05 were 
considered statistically significant. The statistical 
analysis was carried out with the aid of GraphPad 
Prism 5.03 (GraphPad Software Inc., CA, USA). 
 
 
Results 
 
Percentage Yield of PEVA 
The result (Table 2) showed that the 
percentage yield of PEVA is 8.28 ± 0.15 (n=3). 
Table 2: Percentage (%) Yield of PEVA 
 Weight of air-dried and 
pulverized leaves (g) 
Yield of PEVA (g) Percentage (%) yield of 
PEVA 
1st Extraction Process 500 41.25 8.25 
2nd Extraction Process 500 40.20 8.04 
3rd Extraction Process 500 42.80 8.56 
 
 
Food Consumption (g) and Body Weight (g) 
The study recorded a significant decrease in 
the food consumption of rats (Figure 1a) in all Cd-
treated groups, that is Groups 2, 3, 4 and 5 (4.10 ± 
0.64, 9.80 ± 1.07, 5.80 ± 1.28 and 4.20 ± 1.36, 
respectively) when compared with their respective 
baseline (18.00 ± 2.18, 17.20 ± 1.38, 15.20 ± 1.19 and 
15.00 ± 1.61) (p < 0.05). At the fourth week of the 
study, a significant increase (86.39 ± 14.89 %) was 
observed in these groups when compared with the 2 
weeks PEVA-treated groups (14.00 ± 0.63, 10.00 ± 
0.89 and 7.80 ± 0.58, respectively) (p < 0.05). 
However, no significant decrease was recorded in 
Group 2 (11.80 ± 1.93) at the end of the study when 
compared with the baseline (18.00±2.18) (t = 2.129; F 
= 1.276; P = 0.0659). 
 
 
Figure 1: Effects of PEVA on food consumption (a.) and body 
weight (b.) of rats exposed to cadmium toxicity 
 
There was a significant decrease in the body 
weight of rats (Figure 1b) in all Cd-treated groups, that 
is Groups 2, 3, 4 and 5 (132.6 ± 7.11, 133.6 ± 4.32, 
129.6 ± 4.27 and 125.2 ± 3.43) when compared with 
their respective baseline (167.0 ± 7.29, 161.4 ± 5.20, 
158.8 ± 2.33 and 160.4 ± 4.45) (p < 0.05). At the end 
of the study, the toxic group (2) never recovered from 
the weight loss associated with exposure to Cd 
toxicity (167.0±7.29 to 157.0±9.11). However, a 
statistically insignificant increase in body weight of the 
PEVA-treated groups, that is Groups 3, 4 and 5 (173.0 
± 15.05, 189.2 ± 8.53 and 168.6 ± 8.80, respectively) 
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was recorded when compared with their respective 
baselines (161.4 ± 5.20, 158.8 ± 2.33 and 160.4 ± 
4.45) (p > 0.05) at the end of the study period. 
 
Relative Kidney Weight (%) 
The study recorded a significant increase in 
relative kidney weight of rats (Figure 2) in Group 2 
(0.42 ± 0.02) when compared with Group 1 (0.31 ± 
0.03) (t = 3.051; F = 2.250; p < 0.05). The PEVA-
treated groups (3, 4 and 5) recorded no significant 
difference at week two (0.49 ± 0.02; 0.40 ± 0.04; and 
0.48±0.01, respectively) when compared with group 2 
(0.47 ± 0.02). There was a duration dependent 
significant decrease in Group 2 between weeks 2 and 
4 of recovery period (0.64 ± 0.08 and 0.41 ± 0.02, 
respectively). 
 
Figure 2: Effects of PEVA on the relative kidney weight of rats 
exposed to cadmium toxicity. Each value represents mean ± S.E.M 
(n = 5); *=significantly different from control (p < 0.05); δ = 
significantly different from toxic group (p < 0.05); #= significantly 
different from 2 weeks Cd + Recovery group (p < 0.05) 
 
Plasma Creatinine (mg/dl), Urine Creatinine 
(mg/dl) and Creatinine Clearance (ml/min x10
-3
) 
Exposure to Cd toxicity induced a significant 
increase in plasma creatinine of the rats (Figure 3a) in 
the Group 2 (1.97 ± 0.01) when compared with Group 
1 (0.80 ± 0.02) (t = 52.32; F = 4.000; p < 0.05). This 
was accompanied by a significant decrease in urine 
creatinine levels (Figure 3b) in the Group 2 (13.86 ± 
1.85) when compared with Group 1 (37.84 ± 0.71) (t = 
52.32; F = 6.789; p < 0.05).  
Also, the period of Cd intoxication was 
marked with a significant decrease in the creatinine 
clearance of the rats (Figure 3c) in Group 2 (0.84 ± 
0.005) when compared with Group 1 (4.43 ± 0.14) (t = 
25.63; F = 784.0; p < 0.05). These alterations were, 
however, observed to be attenuated in duration, non 
dose-dependent fashion when compared with the 
respective control values (Figure 3a, b and c). 
 
 
 
Figure 3: Effects of PEVA on plasma creatinine (a.), urine creatinine 
(b.) and creatinine clearance (c) of rats with Cd-induced kidney 
injury. Each value represents mean ± S.E.M (n = 5); *= significantly 
different from control (p < 0.05); δ= significantly different from toxic 
group (p < 0.05); #= significantly different from 2 weeks toxic 
recovery group (p < 0.05); α= significantly different from 4 weeks 
toxic recovery group (p < 0.05) 
 
Plasma Urea (mg/l), Urine Urea (g/l) and Urea 
Clearance (ml/min x10
-5
) 
 Cd intoxication induced a significant increase 
in plasma urea of the rats (Figure 4a) in Group 2 
(120.60 ± 7.85) when compared with Group 1 (34.69 ± 
2.32) (t = 10.50; F = 11.45; p < 0.05). This was 
accompanied by a significant decrease in urine urea 
of the rats (Figure 4b) in Group 2 (192.50 ± 0.52) 
when compared with Group 1 (71.14 ± 0.80) (t = 
127.2; F = 2.367; p < 0.05). Also recorded was a 
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significant decrease in the urea clearance of rats in 
Group 2 (3.17 ± 0.62) when compared with Group 1 
(51.00 ± 14.00) (t = 3.41; F = 509.90; p < 0.05), during 
the period of Cd intoxication. These Cd-induced 
alterations in urea levels were also observed to be 
reversed in duration, non dose-dependent fashion 
when compared with the respective control values 
(Figure 4a, b and c). 
 
 
 
Figure 4: Effects of PEVA on plasma Urea (a.), urine urea (b.) and 
urea clearance (c) of rats with Cd-induced kidney injury. Each value 
represents mean ± S.E.M (n = 5); *= significantly different from 
control (p < 0.05); δ= significantly different from toxic group (p < 
0.05); #= significantly different from 2 weeks toxic recovery group (p 
< 0.05); α= significantly different from 4 weeks toxic recovery group 
(p < 0.05) 
Plasma Glucose (mg/dl) and Urine Glucose 
(mg/ml) 
Both plasma glucose (311.87 ± 1.36) (Figure 
5a) and urine glucose levels (38.19 ± 1.39) (Figure 
5b) were found to be significantly increased in the 
Group 2 when compared with their respective Group 
1; (115.31 ± 1.86) (t = 85.31; F = 1.870; p < 0.05) and 
(20.10 ± 1.21) (F = 1.320; p < 0.05). PEVA treatment 
attenuated plasma and urine glucose aberrations in 
rats exposed to Cd toxicity in a dose-dependent 
fashion with a relative potency of 400 mg/kg > 200 
mg/kg > 100 mg/kg (Figure 3.7a & b). However, a 
significant decrease in plasma glucose was recorded 
in Group 2 at 2 week recovery period (281.78 ± 2.40) 
when compared with the toxic group (311.87 ± 1.36) 
(F= 3.114; p<0.05).  
 
 
Figure 5: Effects of PEVA on plasma glucose (a.) and urine glucose 
(b.) of rats with Cd-induced kidney injury.Each value represents 
mean ± S.E.M (n = 5); *= significantly different from control (p < 
0.05); δ= significantly different from toxic group (p < 0.05); #= 
significantly different from 2 weeks toxic recovery group (p < 0.05); 
α= significantly different from 4 weeks toxic recovery group (p < 
0.05) 
This was found to be significantly decreased 
in the PEVA-treated groups (3, 4 and 5) at both week 
2 (165.20 ± 1.82; 211.61 ± 1.79; and 220.02 ± 1.56, 
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respectively) and week 4 (92.10 ± 2.02; 101.97 ± 
2.08; and 92.28 ± 2.09, respectively). At the end of the 
study, there was a significant decrease in the urine 
level of glucose in the PEVA-treated groups (3, 4 and 
5) (14.62 ± 1.21; 17.36 ± 1.14; 16.08 ± 1.25) when 
compared with Group 2 (38.19±1.39) (F = 79.34; p < 
0.0001). 
 
Non- enzymatic Antioxidant Status (GSH) 
(μg/mg protein) and Levels of Lipid 
Peroxidation (TBARS) (nmol/mg protein) 
The GSH level in the renal tissue of the rats 
(Figure 6a) in Group 2 (0.74 ± 0.08) was significantly 
decreased when compared with Group 1 (2.73 ± 0.11) 
(t = 14.63; F = 1.891; p < 0.05). There was no 
significant difference in the PEVA-treated groups (3, 4 
and 5) at 2 weeks recovery period (2.88 ± 0.07; 2.77 ± 
0.09; and 2.68 ± 0.08, respectively) when compared 
with 4 weeks PEVA-treated groups (2.72 ± 0.12; 2.88 
± 0.10; and 2.62 ± 0.16, respectively) and Group 1 
(2.73 ± 0.11).  
 
 
Figure 6: Effects of PEVA on renal levels of GSH (a.) and TBARS 
(b.) in rats with Cd-induced kidney injury. Each value represents 
mean ± S.E.M (n = 5); *= significantly different from control (p < 
0.05); δ= significantly different from toxic group (p < 0.05); #= 
significantly different from 2 weeks toxic recovery group (p < 0.05); 
α= significantly different from 4 weeks toxic recovery group (p < 
0.05) 
Also recorded was a statistically significant 
decrease in during 2 weeks recovery period in Group 
2 (1.07 ± 0.07) when compared with 4 weeks recovery 
period in Group 2 (1.86 ± 0.23) (F = 2.469; p < 0.05). 
There was a significant increase in TBARS 
level (Figure 6b) in the Group 2 (114.90 ± 2.16) when 
compared with the Group 1 (50.63 ± 1.32) (t = 25.39; 
F = 2.678; p < 0.05). There was no significant 
difference in the PEVA-treated groups (3, 4 and 5) at 
2 weeks recovery period (47.82 ± 1.44; 46. 97 ± 1.21; 
48.23 ± 2.20) when compared with the PEVA-treated 
groups at week 4 (51.07 ± 2.15; 46.99 ± 3.21; 51.23 ± 
2.33) as well as with Group 1 (50.63 ± 1.32). Also 
recorded was a statistically significant decrease in 
levels of TBARS in Group 2 at 2 weeks recovery 
(94.54 ± 1.27) when compared with 4 weeks recovery 
period (63.23 ± 1.31) (F= 1.064; p < 0.05). 
 
 
 
Figure 7: Photomicrographs of renal tissues showing the effects of 
PEVA treatment following Cd-induced kidney injury in rats 
(Magnification 400x).A = Control group; B = Toxic group (5 days Cd 
treatment); C = Toxic group (Cd + 2 weeks recovery period); D = 
Toxic group (Cd + 4 weeks recovery period); E = Cd + 100 mg/kg 
PEVA for 2 weeks; F = Cd + 200 mg/kg PEVA for 2 weeks; G = Cd 
+ 400 mg/kg PEVA for 2 weeks; H = Cd + 100 mg/kg PEVA for 4 
weeks; I = Cd + 200 mg/kg PEVA for 4 weeks; J = Cd + 400 mg/kg 
PEVA for 4 weeks; K = 100 mg/kg PEVA treatment + 2 weeks 
recovery period; L = 200 mg/kg PEVA treatment + 2 weeks 
recovery period; M = 400 mg/kg PEVA treatment + 2 weeks 
recovery period;  Yellow arrow = atrophic glomerulus; Red arrow = 
shrunken glomerulus; Black single arrow = Bowman’s capsular 
space; Black double arrow = Severe cloudy swelling of the proximal 
convoluted tubule; G = Glomerulus; P = Proximal convoluted 
tubules and D = Distal convoluted tubules 
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Histopathological Investigation  
The photomicrograph of the toxic group 
(Figure 7B) showed evidence of distorted renal 
corpuscles with atrophic glomerulus (yellow arrow), 
loss of cellular constituents in the tubules and severe 
cloudy swelling of the proximal convoluted tubule 
(black double arrow). This was in contrast to the 
control group (Figure 7A) that showed intact renal 
corpuscles with normal appearing glomerulus (G) and 
tubules; proximal convoluted tubules (P), distal 
convoluted tubules (D) as well as intact Bowman’s 
capsular space (black single arrow). 
The Cd + recovery groups (Figures C and D) 
showed a duration-dependent improvement in the 
renal histoarchitecture of the rats when compared with 
the toxic group. However, these improvements were 
found to be less significant in a duration-dependent 
fashion when compared with the PEVA-treated groups 
at 2 weeks of PEVA treatment (Figures 7 E, F and G), 
4 weeks of PEVA treatment (Figures 7 H, I and J) and 
with the groups that were left to recover for 2 weeks 
after PEVA treatment (Figures 7 K, L and M). Within 
the PEVA-treated groups, the improvements that were 
observed were duration-dependent but not dose-
dependent. This was with a relative potency of 200 
mg/kg > 100 mg/kg > 400 mg/kg body weight of PEVA 
administration. It is worthy of note to state that the 
groups that received 400 mg/kg PEVA still showed 
marked evidence of atrophic (yellow arrow) and 
shrunken (red arrow) glomeruli even after 4 weeks of 
PEVA treatment (Figure 7J) and 2 weeks recovery 
period after PEVA treatment (Figure 7M). 
 
 
Discussion 
 
The study was in three phases. The first and 
second phases investigated the effects of two and 
four weeks treatment with polyphenol-rich extract of 
leaves of Vernonia amygdalina (PEVA), respectively, 
on the renal function of rats with cadmium-induced 
kidney injury while the third phase investigated the 
impact of a two week recovery period from PEVA 
treatment in rats with cadmium-induced kidney injury. 
Exposure to Cd toxicity was associated with 
tiredness and reduced appetite, as observed in the 
rats. This explains the reduction in body weight that 
was recorded in the study. Katherine et al [23] 
reported that in any individual, weight gain or loss is a 
function of a balance between food consumption and 
the rate of energy expenditure. Therefore, the 
reduction in body weight that was recorded was a 
consequence of Cd-induced alteration in feeding 
pattern. Within neural circuitry, the “key controller” that 
maintains energy homeostasis is the hypothalamus 
[23]. The brain has been reported in literature to also 
be an area of Cd bioaccumulation [24, 25, 26] with 
undesirable effects on the hypothalamus [27, 28]. 
Subject to further investigation and verification, Cd 
toxicity may have resulted in the suppression of the 
hypothalamic centre for energy expenditure and food 
consumption, with a consequent reduction in appetite. 
PEVA treatment was associated with a duration-
dependent improvement in the appetite and feeding 
pattern of rats, suggesting a possible modulatory 
effect of PEVA on appetite to restore homeostasis of 
feeding pattern in subjects that have been exposed to 
Cd toxicity. 
The physiological explanation for the increase 
in both plasma and urine glucose levels is splay. This 
is the concentration difference between a substance 
transport maximum and its renal threshold. It is 
evident that the splay for blood glucose was 
significantly reduced during the period of exposure to 
Cd toxicity; since the magnitude of splay is inversely 
proportional to the avidity with which the transport 
mechanism binds the substance it transports [29]. Cd 
has been reported to target various transporters in 
brush borders and baso-lateral membranes of the 
kidney [30]. This study recorded that Cd toxicity 
induced hyperglycemia which was sufficient to induce 
glycosuria, with the renal threshold for glucose being 
exceeded. However, the representative photomicro-
graph of the toxic group revealed loss of cellular 
constituents and severe cloudy swelling in the 
proximal convoluted tubules, where almost all glucose 
reabsorption takes place [31]. This suggests that the 
mechanism by which Cd induced glycosuria was both 
induction of hyperglycemia and reduction in renal 
reabsorptive capacity for glucose. PEVA treatment 
was observed to have significantly reversed the Cd-
induced alteration in plasma and urine levels of 
glucose in a dose-dependent fashion, suggesting its 
potential in restoring body glucose homeostasis. It is, 
however, worthy of note to state that the dose-
dependent decrease in the plasma glucose level that 
was associated with PEVA treatment culminated in 
hypoglycemia in the group that received the highest 
dose, in a manner that was duration-dependent. This 
suggests a high risk profile of PEVA administration at 
high doses.  
The significant increase in the relative kidney 
weight (RKW) that was recorded is in contrast to 
some reports on the effects of Cd toxicity on RKW. 
For instance, Borde et al [32] and Onwuka et al [33] 
reported that Cd toxicity induced significant decrease 
in RKW. These contrasting reports could have been 
as a result of difference in the salts of Cd that were 
used for the studies; while this study investigated Cd 
in the form of cadmium sulphate, the former 
investigated cadmium in the form of cadmium 
chloride. Similar finding (significant increase in RKW) 
was reported by Ige et al [34], who used cadmium in 
form of cadmium sulphate. This could mean that salts 
of Cd can induce toxicity in unique patterns that are 
peculiar to each salt. The significant increase may 
have resulted from the features of severe cloudy 
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swelling as revealed in the representative 
photomicrograph. An apparent anti-inflammatory 
potential of PEVA was demonstrated by its ability to 
significantly reverse the Cd-induced increase in RKW.  
The increased level of TBARS observed in 
the renal tissues of rats with Cd toxicity indicated a 
high degree of lipid peroxidation and oxidative stress. 
Lipid peroxidation, though indirectly involved in the 
generation of free radicals, is considered as the 
primary mechanism for Cd-induced toxicity [35-38]. 
Because of the presence of sulfhydryl group in it, GSH 
is a non-enzymatic antioxidant which acts as a first 
line of defense against oxidative stress [39]. The 
significant reduction in GSH levels that was recorded 
can be attributed to the increased use of GSH (by the 
renal tissues) to mop up excessive Reactive Oxygen 
Species (ROS) that were generated during the 
process of Cd-induced renal injury. Inducing ROS 
generation through oxidative damage to cellular 
organelles is the mechanism by which Cd exerts its 
toxic effects [40]. Reactions of these ROS, which 
consist mainly of O2
+
, H2O2 and OH
+
 [41], with cellular 
biomolecules have been shown to lead to lipid 
peroxidation, membrane protein damage, altered anti-
oxidant system, altered gene expression, DNA 
damage and apoptosis [42, 40]. The GSH report in 
this study is consistent with the other reports in which 
GSH concentration was decreased during exposure to 
Cd toxicity [43, 41]. The ability of Cd to generate free 
radicals is a pointer to the possibility of ameliorating 
the oxidative stress that it induces with the use of 
potent antioxidants. PEVA administration to rats that 
were exposed to Cd toxicity reinstated normal levels 
of both TBARS and GSH in the renal tissues, possibly 
by significantly reducing Cd reaction with cellular 
biomolecules. This suggests that PEVA is a potent 
antioxidant. The efficacy of PEVA in this study, as an 
antioxidant, became obvious during the 4th week 
treatment period and therefore sustained. 
The protection of cell constituents against 
oxidative damage through scavenging of free radicals 
is a concept that is considered an oversimplified view 
of the mechanism of polyphenol action [44]. The 
biological effects of polyphenols may far exceed the 
modulation of oxidative stress in biological systems 
[45]. 
The record on plasma and urine creatinine 
level is consistent with previous findings [46, 47, 48, 
49]. A significant increase in plasma levels of 
creatinine is usually associated with a compromise to 
the filtering capacity of the kidney [50] hence, 
creatinine clearance is a function of glomerular 
filtration rate. As depicted by features of atrophic 
glomeruli, the significant increase in plasma creatinine 
can be attributed to a compromise to the renal 
filtration capacity following exposure to Cd toxicity. 
Also, after a significant decrease, creatinine clearance 
was observed to be significantly increased in a 
duration-dependent fashion in the PEVA-treated 
groups. This potential of PEVA to significantly reverse 
the Cd-induced alteration in creatinine clearance, 
buttressed by the corresponding photomicrographs, 
may have resulted from its antioxidant effect. 
However, the observations of this study portray PEVA 
as having a potential role, possibly, in tissue 
regeneration as a means of improving levels of 
plasma creatinine as well as creatinine clearance in 
subject exposed to Cd toxicity. The (precise) 
mechanism by which polyphenols reinstate normal 
levels of creatinine in biological systems is worthy of 
further investigation. 
The integration of amino acids into proteins is 
inhibited by Cd, causing an increase in blood urea 
level [49]. Also, tubular secretion and reabsorption 
(through urea transport proteins) are the major factors 
that regulate the excretion of urea from the body [51]. 
PEVA’s ability to significantly reinstate normal levels 
of urea suggests its potential to enhance the 
integration of amino acids into proteins, thus abating 
Cd-induced nephritis and or mediate possible 
alterations in urea transport proteins in the renal 
tubules to restore urea homeostasis. The 
representative photomicrographs depicted intact renal 
histoarchitecture when compared with that of the 
control. This is, however, subject to further 
investigation and verification. 
It is noteworthy to state that rats that were left 
untreated after exposure to Cd toxicity showed 
remarkably steady degree of amelioration when 
compared with the toxic group. However, when 
compared with the PEVA-treated groups, there was a 
significant difference; with PEVA-treated groups 
showing between “two-fold to over-six fold” increase in 
ameliorative capacity as opposed to when rats were 
left untreated. Based on this observation, it can be 
deduced that renal tissues of rats with Cd-induced 
kidney injury have the potential to attempt the 
restoration of normal renal function in a duration-
dependent manner, provided complete abstinence 
from Cd exposure is maintained.  
 Although PEVA showed significant changes in 
the biochemical and histological aberrations that were 
induced by exposure to Cd toxicity, its relative potency 
was in the order 200 mg/kg PEVA> 100 mg/kg PEVA> 
400 mg/kg PEVA. This shows that the ameliorative 
potential of the extract is not dose-dependent. Also, 
prolonged administration of high doses can potentiate 
further injury rather than sustaining ameliorative 
potentials. It was observed that a 2 week 
administration of PEVA for the adopted graded doses 
in the PEVA-treated groups produced effects that 
were similar to the toxic recovery groups for all 
biochemical parameters that were measured. This fact 
was supported by the representative 
photomicrographs, thus indicating that the beneficial 
effects of PEVA administration are duration-
dependent. Therefore, there must be a balance 
between choice of therapeutic dose and duration of 
administration. 
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It is recommended that the consumption of 
PEVA or, at least, fresh leaves (rather than blanching) 
of Vernonia amygdalina should be encouraged in 
order to maximize its health benefits as a relatively 
cheaper and potential herbal alternative in the 
treatment or management of subjects with Cd-induced 
kidney injury, which is otherwise expensive to manage 
or treat with the use of conventional therapy.  
In conclusion, the administration of 
polyphenol-rich extract of the leaves of Vernonia 
amygdalina (PEVA) reversed the compromise of renal 
function that was induced by cadmium toxicity in rat 
model. The antioxidant, anti-inflammatory and 
membrane stabilizing activities can be considered as 
the key factors responsible for the ameliorative effect 
of PEVA. Therefore, it represents a prospective 
therapeutic choice to ameliorate the renal oxidative 
injury inflicted by Cd in exposed subjects. 
Nevertheless, a high risk profile at high doses is not 
unlikely. 
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